MALI
MALI Platform
AI Stock Research

Rubric Capital Management LP: latest 13F holdings

For the quarter ending 30 September 2026, Rubric Capital Management LP reported 89 positions worth $10.6B in total, filed with the SEC on 16 November 2026. The quarter before, it reported $10.9B.

Read the filing at SEC EDGAR
Checked: the cover page's entry count and total value match the holdings table.

Top 50 positions by value

#IssuerClassValueWeightSharesvs quarter before
1TALEN ENERGY CORPCOM$1.1B10.58%3,602,171Unchanged
2FTAI AVIATION LTDSHS$701.5M6.59%4,200,000Added 40.0%
3VIATRIS INCCOM$637.9M5.99%36,000,000Added 5.4%
4TEVA PHARMACEUTICAL INDS LTDSHS$458.4M4.30%11,575,000New
5GOLAR LNG LTDSHS$437.6M4.11%9,208,911Added 0.3%
6GILDAN ACTIVEWEAR INCCOM$397.6M3.73%9,327,914Added 107.3%
7BGC GROUP INCCL A$303.2M2.85%26,295,028Added 10.5%
8GDS HLDGS LTDSPONSORED ADS$278.4M2.61%8,913,999Added 1734.6%
9ROIVANT SCIENCES LTDSHS$273.6M2.57%7,481,524Added 24.7%
10VISTRA CORPCOM$265.5M2.49%1,919,369Added 6.9%
11TRANSALTA CORPCOM$253.7M2.38%21,000,000Added 3.8%
12ARCUTIS BIOTHERAPEUTICS INCCOM$222.6M2.09%8,421,577Added 1.8%
13KINIKSA PHARMACEUTICALS INTLORD SHS CL A$209.9M1.97%2,813,469Cut 29.7%
14DELEK US HLDGS INC NEWCOM$191.8M1.80%2,687,449Unchanged
15ZYMEWORKS INCCOM$185.4M1.74%7,000,000Unchanged
16AMCOR PLCCOM NEW$180.0M1.69%4,300,000Added 3.3%
17AMNEAL PHARMACEUTICALS INCCOM STK CL A$171.9M1.61%8,536,755Cut 16.0%
18CIMPRESS PLCSHS EURO$160.0M1.50%2,075,000Added 18.6%
19GEO GROUP INCCOM$158.1M1.48%5,187,353Added 25.6%
20PENNYMAC FINL SVCS INC NEWCOM$148.1M1.39%2,400,000Added 41.2%
21ECHOSTAR CORPCL A$147.4M1.38%1,648,611New
22INDIVIOR PHARMACEUTICALS INCCOM$138.5M1.30%3,862,989New
23CORECIVIC INCCOM$130.0M1.22%4,030,385Added 41.5%
24ADMA BIOLOGICS INCCOM$123.9M1.16%12,352,584Added 32.3%
25LIBERTY GLOBAL LTDCOM CL A$121.2M1.14%13,278,653Added 13.0%
26INTEGRA LIFESCIENCES HLDGS CCOM NEW$119.7M1.12%7,353,934Cut 5.2%
27FLUOR CORPCOM$118.3M1.11%2,469,762Cut 50.8%
28NURIX THERAPEUTICS INCCOM$117.8M1.11%4,966,827Cut 31.3%
29LIBERTY LATIN AMERICA LTDCOM CL C$116.3M1.09%14,145,430Cut 9.6%
30MANNKIND CORPCOM NEW$114.8M1.08%29,430,000Added 63.5%
31ALVOTECHORDINARY SHARES$114.6M1.08%19,761,339Added 26.1%
32APTIV PLCCOM SHS$114.1M1.07%2,651,364New
33CORE SCIENTIFIC INC NEWCOM$111.9M1.05%7,000,000New
34LIBERTY GLOBAL LTDCOM CL C$99.6M0.94%11,201,830Added 21.0%
35ENOVIS CORPORATIONCOM$96.8M0.91%5,300,000Added 35.9%
36EDGEWELL PERSONAL CARE COCOM$94.6M0.89%3,504,525Cut 1.1%
37MEIRAGTX HLDGS PLCCOM$92.7M0.87%8,427,279Cut 7.4%
38GALAXY DIGITAL INC.CL A$91.0M0.85%4,000,000Added 70.7%
39NEWELL BRANDS INCCOM$87.1M0.82%16,500,000Added 3.1%
40ECOVYST INCCOM$85.6M0.80%8,711,888Added 6.1%
41MISSION PRODUCE INCCOM$78.4M0.74%5,981,953Unchanged
42OPKO HEALTH INCCOM$76.9M0.72%47,791,243Unchanged
43RENEW ENERGY GLOBAL PLCCL A SHS$75.2M0.71%11,000,000Unchanged
44SUPERNUS PHARMACEUTICALSCOM$74.9M0.70%1,739,892New
45COMPASS INCCL A$73.0M0.69%8,218,394Unchanged
46VENTURE GLOBAL INCCOM CL A$68.4M0.64%5,410,280Unchanged
47STRATASYS LTDSHS$67.7M0.64%8,150,000Added 1.9%
48BIOHAVEN LTDCOM$65.1M0.61%4,875,000Added 183.2%
49SIX FLAGS ENTERTAINMENT CORPCOM$63.7M0.60%5,944,841New
50SCHRODINGER INCCOM$61.5M0.58%1,980,830Cut 69.0%

Showing the largest 50 of 89 positions. Every position is in MALI's SEC Financials & 13F workspace.

New this quarter

  • TEVA PHARMACEUTICAL INDS LTD · $458.4M
  • ECHOSTAR CORP · $147.4M
  • INDIVIOR PHARMACEUTICALS INC · $138.5M
  • APTIV PLC · $114.1M
  • CORE SCIENTIFIC INC NEW · $111.9M
  • SUPERNUS PHARMACEUTICALS · $74.9M
  • SIX FLAGS ENTERTAINMENT CORP · $63.7M

Sold out

  • TEVA PHARMACEUTICAL INDS LTD · was $527.7M
  • ZOOM COMMUNICATIONS INC · was $238.7M
  • AMAZON COM INC · was $214.5M
  • MERCURY GENL CORP NEW · was $164.3M
  • TREVI THERAPEUTICS INC · was $46.7M
  • TRIPADVISOR INC · was $33.4M
  • ANI PHARMACEUTICALS INC · was $21.4M
  • UNIQURE NV · was $18.8M
  • PROTO LABS INC · was $8.9M
  • GRUPO AEROMEXICO SAB DE CV · was $8.4M

Reading a 13F

A 13F lists a manager's long positions in US-listed securities at the end of a quarter, filed up to 45 days later. It leaves out short positions, cash and most non-US holdings, so it is a partial, delayed view of a portfolio. Nothing here is investment advice.

Positions are named as the manager filed them. Values are the filing's own, in US dollars; changes compare share counts with the quarter before.

Other managers